Status:
UNKNOWN
FOCUS for Pediatric Sickle Cell Disease and Cancer
Lead Sponsor:
Georgia State University
Conditions:
Pediatric Cancer
Sickle Cell Disease
Eligibility:
All Genders
12-18 years
Phase:
NA
Brief Summary
Aim. Pilot FOCUS. A pilot randomized controlled trial will compare FOCUS to standard care. Investigators will randomize a total of 60 12- to 18-year-old patients to either FOCUS intervention (n=15 wit...
Detailed Description
Sickle cell disease (SCD) and cancer are medical conditions in youth that are associated with psychosocial problems including anxiety and depressive symptoms and impaired health-related quality of lif...
Eligibility Criteria
Inclusion
- 1\) diagnosis of sickle cell disease, any hemoglobin type or diagnosis of leukemia, lymphoma, or solid tumor
- 2\) inpatient at CHOA
- 3\) 12-18 years of age
- 4\) English speaking
- 5\) owns a smartphone with camera.
Exclusion
- 1\) report of active psychosis or active suicidal ideation in the adolescents
- 2\) significant documented developmental delay, autism spectrum disorder, or significant intellectual impairment, as these comorbidities may confound the study aims by impacting the dependent measures.
Key Trial Info
Start Date :
January 10 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 30 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04075877
Start Date
January 10 2020
End Date
July 30 2021
Last Update
November 13 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Georgia State University
Atlanta, Georgia, United States, 30302
2
Children's Healthcare of Atlanta
Atlanta, Georgia, United States, 30342